Vaxart, Inc.: Form 10-Q for the period ended Jun 30, 2020
Filed with the SEC on Aug 6, 2020 and accepted by EDGAR at Aug 6, 2020, 16:08 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-04-01 to 2020-06-30 | $523.0k | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 6 months2020-01-01 to 2020-06-30 | $3.4m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Research and development | 3 months2020-04-01 to 2020-06-30 | $5.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2020-01-01 to 2020-06-30 | $6.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2020-04-01 to 2020-06-30 | −$8.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2020-01-01 to 2020-06-30 | −$9.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2020-04-01 to 2020-06-30 | $26.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2020-01-01 to 2020-06-30 | $179.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-04-01 to 2020-06-30 | −$9.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2020-01-01 to 2020-06-30 | −$10.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-04-01 to 2020-06-30 | −$0.12 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months2020-01-01 to 2020-06-30 | −$0.15 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months2020-01-01 to 2020-06-30 | −$3.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2020-01-01 to 2020-06-30 | $13.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2020-06-30 | $44.4m | us-gaap:Cash |
| Current assets | At period end2020-06-30 | $45.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-06-30 | $64.2m | us-gaap:Assets |
| Current liabilities | At period end2020-06-30 | $11.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-06-30 | $24.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-06-30 | $40.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001437749-20-016864. Last ingested by Listed: Nov 5, 2026, 18:48 ET. Listed shows no prices and gives no investment advice.